Epithelial ovarian cancer: Difference between revisions
Jump to navigation
Jump to search
Hannan Javed (talk | contribs) No edit summary |
Hannan Javed (talk | contribs) No edit summary |
||
| Line 11: | Line 11: | ||
!Result of mutation | !Result of mutation | ||
|- | |- | ||
| | |EGFR(HER-1) | ||
| | |||
| | |||
|- | |||
|HER-2 | |||
| | |||
| | |||
|- | |||
|Src | |||
| | |||
| | |||
|- | |||
|CSF-1/fms | |||
| | |||
| | |||
|- | |||
|ILGF/ILGFR | |||
| | |||
| | |||
|- | |||
|k-ras | |||
| | |||
| | |||
|- | |||
|b-raf | |||
| | |||
| | |||
|- | |||
|TGF-β | |||
| | |||
| | |||
|- | |||
|myc | |||
| | |||
| | |||
|- | |||
|Cyclin D/Cdk4/6 | |||
| | |||
| | |||
|- | |||
|Cyclin E/Cdk2 | |||
| | |||
| | |||
|- | |||
|Cyclin B/Cdk1 | |||
| | |||
| | |||
|- | |||
|p16 | |||
| | |||
| | |||
|- | |||
|p27 (kip-1) | |||
| | |||
| | |||
|- | |||
|p21 (WAF-1) | |||
| | |||
| | |||
|- | |||
|NFκB | |||
| | |||
| | |||
|- | |||
|NOEY(ARHI) | |||
| | |||
| | |||
|- | |||
| | |||
| | |||
| | |||
|- | |||
| | |||
| | |||
| | |||
|- | |||
| | |||
| | |||
| | |||
|- | |||
| | |||
| | |||
| | |||
|- | |||
| | |||
| | | | ||
| | | | ||
Revision as of 14:55, 26 February 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Hannan Javed, M.D.[2]
| Possible genetic alteration in epithelial ovarian cancers | ||
|---|---|---|
| Protein | Normal function | Result of mutation |
| EGFR(HER-1) | ||
| HER-2 | ||
| Src | ||
| CSF-1/fms | ||
| ILGF/ILGFR | ||
| k-ras | ||
| b-raf | ||
| TGF-β | ||
| myc | ||
| Cyclin D/Cdk4/6 | ||
| Cyclin E/Cdk2 | ||
| Cyclin B/Cdk1 | ||
| p16 | ||
| p27 (kip-1) | ||
| p21 (WAF-1) | ||
| NFκB | ||
| NOEY(ARHI) | ||